全玻片成像市場規模、佔有率及成長分析（按技術、應用、最終用戶和地區分類）－2026-2033年產業預測

預計到 2024 年，全球全切片成像市場規模將達到 12.7 億美元，到 2025 年將達到 14.7 億美元，到 2033 年將達到 47.6 億美元，在預測期（2026-2033 年）內，複合年成長率為 15.8%。

隨著數位病理學技術的進步不斷提升診斷的準確性和效率，全球全切片成像市場正經歷變革性成長。包括醫院、製藥公司、生物技術公司和病理檢查室在內的眾多相關人員都在積極採用這項技術，該技術透過自動化演算法和高速系統顯著加快了影像擷取速度。全切片成像技術從傳統成像技術發展而來，拓展了其應用範圍，在確保高品質結果的同時，實現了更快的診斷。鑑於其重要的臨床意義，專業機構已更新指南，確認全切片影像技術在病理診斷中的有效性，以確保患者照護。隨著這項技術的不斷發展，它有望重新定義病理學，並為醫療服務提供者提供創新工具，以改善患者預後並簡化診療流程。

全球全切片成像市場促進因素

慢性疾病（包括癌症）的日益增加凸顯了對精準高效診斷方案的需求，使得全切片影像成為病理檢查室和醫療專業人員的必備技術。這種對精準診斷日益成長的需求推動了創新成像工具的應用，從而提高了疾病檢測的速度和可靠性。隨著醫療專業人員致力於改善患者預後，將全切片影像整合到常規病理工作流程中對於促進複雜組織樣本的分析和解讀至關重要。因此，這一趨勢凸顯了先進成像技術在現代醫學實踐和研究中的重要性。

限制全球全切片成像市場的因素

全球全切片成像市場面臨處理大量敏感患者數位化資訊的重大挑戰。這引發了人們對資料安全和隱私的擔憂，相關人員日益關注未授權存取和洩露敏感患者資料的潛在風險。這些擔憂構成障礙，可能阻礙全切片成像技術在臨床環境中的廣泛應用和整合。確保強而有力的安全措施並遵守隱私法規對於應對這些挑戰、建立醫病信任至關重要。

全球全切片成像市場趨勢

全球全切片成像市場正呈現出一個顯著的趨勢，即全切片成像 (WSI) 系統與實驗室資訊系統 (LIS) 和電子健康記錄 (EHR) 系統整合。這種整合實現了無縫的數據管理和強大的患者記錄管理，從而提高了病理檢查室的整體效率。隨著醫療機構尋求數位化解決方案來最佳化診斷流程，WSI 與 LIS/EHR 系統之間的協同作用變得至關重要。這一趨勢不僅有助於改善醫療專業人員之間的溝通，還有助於做出更明智的決策，從而改善患者預後並提高臨床層面的營運效率。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究

全球全切片成像市場規模（依技術及複合年成長率分類）（2026-2033 年）

• 掃描器
• IT基礎設施
• 觀眾
• 影像管理系統

全球全切片成像市場規模（按應用及複合年成長率分類）（2026-2033 年）

• 遠距病理診斷
• 細胞病理學
• 免疫組織化學
• 血液病理學

全球全切片成像市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

• 醫院
• 製藥和生物製藥公司
• 研究所
• 學術機構
• 研究
• 其他

全球全切片成像市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Danaher Corporation（United States）
• Hamamatsu Photonics KK（Japan）
• 3DHISTECH Ltd.（Hungary）
• Olympus Corporation（Japan）
• Roche Holding AG（Switzerland）
• Koninklijke Philips NV（Netherlands）
• Leica Biosystems Nussloch GmbH（Germany）
• PerkinElmer, Inc.（United States）
• Sectra AB（Sweden）
• Diasorin（Italy）
• Biocare Medical（United States）
• Sakura Finetek（Japan）
• DigiPath（United States）
• Indica Labs（Canada）

結論與建議

Global Whole Slide Imaging Market size was valued at USD 1.27 Billion in 2024 and is poised to grow from USD 1.47 Billion in 2025 to USD 4.76 Billion by 2033, growing at a CAGR of 15.8% during the forecast period (2026-2033).

The global whole slide imaging market is experiencing transformative growth, driven by advancements in digital pathology that enhance diagnostic accuracy and efficiency. Diverse stakeholders, including hospitals, pharmaceutical companies, biotech firms, and pathology labs, are leveraging this technology, which significantly accelerates image acquisition through automated algorithms and high-speed systems. The evolution from traditional imaging methods to whole slide imaging has broadened its application scope, facilitating quicker diagnoses while maintaining high-quality results. Recognizing its clinical importance, professional organizations have updated guidelines to validate whole slide imaging for pathology diagnostics, ensuring timely patient care. As this technology continues to evolve, it is set to redefine pathology, empowering healthcare providers with innovative tools for improved patient outcomes and streamlined processes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Whole Slide Imaging market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Whole Slide Imaging Market Segments Analysis

Global Whole Slide Imaging Market is segmented by Technology, Application, End User and region. Based on Technology, the market is segmented into Scanners, IT Infrastructure, Viewer and Image Management System. Based on Application, the market is segmented into Telepathology, Cytopathology, Immunohistochemistry and Hematopathology. Based on End User, the market is segmented into Hospitals, Pharmaceutical and Biopharmaceutical Companies, Laboratories, Academic Institute, Research and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Whole Slide Imaging Market

The rising prevalence of chronic diseases, including cancer, underscores the need for precise and efficient diagnostic solutions, positioning Whole Slide Imaging as a vital technology for pathology laboratories and healthcare practitioners. This growing demand for accurate diagnostics drives the adoption of innovative imaging tools that enhance the speed and reliability of disease detection. As healthcare professionals strive for improved patient outcomes, the integration of Whole Slide Imaging into routine pathology workflows becomes crucial, facilitating better analysis and interpretation of complex tissue samples. Consequently, this trend highlights the importance of advanced imaging technologies in contemporary medical practice and research.

Restraints in the Global Whole Slide Imaging Market

The Global Whole Slide Imaging market faces significant challenges due to the handling of substantial volumes of sensitive patient information in a digital format. This creates apprehensions surrounding data security and privacy, as stakeholders are increasingly concerned about the potential risks associated with unauthorized access or breaches of confidential patient data. Such concerns can act as a barrier, hindering the broader acceptance and integration of Whole Slide Imaging technologies in clinical settings. Ensuring robust security measures and compliance with privacy regulations will be essential for addressing these issues and fostering trust among healthcare providers and patients alike.

Market Trends of the Global Whole Slide Imaging Market

The Global Whole Slide Imaging market is experiencing a significant trend towards the integration of Whole Slide Imaging (WSI) systems with Laboratory Information Systems (LIS) and electronic health records (EHR). This integration enhances workflow efficiency by enabling seamless data management and robust patient record-keeping, thus improving overall productivity in pathology labs. As healthcare institutions increasingly seek digital solutions to optimize diagnostic processes, the synergy between WSI and LIS/EHR systems is becoming essential. This trend not only fosters improved communication among healthcare professionals but also supports better decision-making, leading to enhanced patient outcomes and streamlined operations within clinical settings.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies

Global Whole Slide Imaging Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Scanners
• IT Infrastructure
• Viewer
• Image Management System

Global Whole Slide Imaging Market Size by Application & CAGR (2026-2033)

• Market Overview
• Telepathology
• Cytopathology
• Immunohistochemistry
• Hematopathology

Global Whole Slide Imaging Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Pharmaceutical and Biopharmaceutical Companies
• Laboratories
• Academic Institute
• Research
• Others

Global Whole Slide Imaging Market Size & CAGR (2026-2033)

• North America (Technology, Application, End User)
  • US
  • Canada
• Europe (Technology, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Danaher Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hamamatsu Photonics K.K. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3DHISTECH Ltd. (Hungary)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Leica Biosystems Nussloch GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sectra AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diasorin (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocare Medical (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sakura Finetek (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DigiPath (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indica Labs (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations